capitol building of the U.S.

SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD)

ByOD Free Marin

The Substance Abuse and Mental Health Services Administration (SAMHSA) applauds provisions included in the 2023 Consolidated Appropriations Act (P.L. 117-328) that will significantly expand access to medication for opioid use disorder (MOUD). The act, signed into law by President Biden on Dec. 29, 2022, amended the Controlled Substances Act to eliminate the requirement for qualified practitioners to first obtain a special waiver to prescribe medications such as buprenorphine for the treatment of opioid use disorder (OUD). This ends a decades-long requirement, originally put in place through the Drug Abuse Treatment Act (DATA) of 2000. With the new law, the patient limits associated with this special waiver also no longer apply.

The removal of the federal requirement for practitioners to obtain a waiver will make it easier for qualified practitioners to prescribe buprenorphine, builds on the Department of Health and Human Services’ (HHS) Overdose Prevention Strategy, and delivers on the call to action in President Biden’s Unity Agenda to address the overdose and addiction crisis.

Read the full Article Here

Similar Posts

Harsh New Fentanyl Laws Ignite Debate Over How to Combat Overdose Crisis
|

Harsh New Fentanyl Laws Ignite Debate Over How to Combat Overdose Crisis

ByOD Free Marin

By Jan Hoffman | The New York Times Three teenage girls were found slumped in a car in the parking lot of a rural Tennessee high school last month, hours before graduation ceremonies. Two were dead from fentanyl overdoses. The third, a 17-year-old, was rushed to the hospital in critical condition. Two days later, she…

The FDA approves the overdose-reversing drug Narcan for over-the-counter sales
|

The FDA approves the overdose-reversing drug Narcan for over-the-counter sales

ByOD Free Marin

By Joe Hernandez / NPR The overdose-reversing drug Narcan could soon be available to buy over the counter without a prescription, the Food and Drug Administration announced Wednesday. The FDA’s approval of the nasal spray Narcan — the brand name for the drug naloxone — means the medication could be more widely available across the U.S….

Biden-⁠Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States

Biden-⁠Harris Administration Designates Fentanyl Combined with Xylazine as an Emerging Threat to the United States

ByOD Free Marin

ATLANTA, GA – Today, Dr. Rahul Gupta, Director of the White House Office of National Drug Control Policy (ONDCP), has officially designated fentanyl adulterated or associated with xylazine as an emerging threat to the United States. Xylazine is a non-opioid tranquilizer approved by the Food and Drug Administration (FDA) for veterinary use but not human use….

Texas scientists create fentanyl vaccine to combat opioid epidemic

Texas scientists create fentanyl vaccine to combat opioid epidemic

ByOD Free Marin

By Adithi Ramakrishnan | The Dallas Morning News To combat the fentanyl epidemic in the United States, researchers at the University of Houston have created a fentanyl vaccine that could help prevent overdoses. They aim to test the vaccine in a human trial within the next year. Fentanyl is a synthetic opioid drug that kills…

White House Challenge

White House Challenge

ByOD Free Marin

Saving Lives From Overdose America’s overdose crisis impacts all of us. Families in small towns, large cities, Tribal lands, and every community in between are affected, no matter who they are, what they look like, or how much money they make. That’s why President Biden named beating the opioid and overdose crisis a key pillar…

Leave a Reply

Your email address will not be published. Required fields are marked *